Lawrence Biegelsen

Stock Analyst at Wells Fargo

(1.81)
# 3,307
Out of 5,044 analysts
56
Total ratings
52.78%
Success rate
-4.42%
Average return

Stocks Rated by Lawrence Biegelsen

Abbott Laboratories
Oct 16, 2025
Maintains: Overweight
Price Target: $142$146
Current: $126.61
Upside: +15.31%
Becton, Dickinson and Company
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $172$184
Current: $184.21
Upside: -0.11%
Insulet
Aug 8, 2025
Maintains: Overweight
Price Target: $330$350
Current: $324.34
Upside: +7.91%
NeuroPace
Mar 14, 2024
Upgrades: Overweight
Price Target: $16$20
Current: $10.62
Upside: +88.32%
Tandem Diabetes Care
Aug 4, 2022
Maintains: Overweight
Price Target: $166$82
Current: $15.10
Upside: +443.05%
Teleflex
Jul 29, 2022
Downgrades: Equal-Weight
Price Target: $248
Current: $130.58
Upside: +89.92%
Intuitive Surgical
Apr 22, 2022
Maintains: Overweight
Price Target: $350$339
Current: $545.39
Upside: -37.84%
REE Automotive
Mar 25, 2022
Initiates: Underweight
Price Target: $1.5
Current: $1.09
Upside: +37.61%
Pulmonx
Feb 24, 2022
Maintains: Equal-Weight
Price Target: $55$27
Current: $1.98
Upside: +1,263.64%
Zimmer Biomet Holdings
Feb 8, 2022
Maintains: Underweight
Price Target: $124$111
Current: $101.14
Upside: +9.75%
Upgrades: Overweight
Price Target: $144
Current: $69.23
Upside: +107.64%
Upgrades: Equal-Weight
Price Target: $56
Current: $77.79
Upside: -28.01%
Maintains: Equal-Weight
Price Target: $68$74
Current: $82.75
Upside: -10.57%
Downgrades: Equal-Weight
Price Target: $77
Current: $82.19
Upside: -6.72%
Upgrades: Overweight
Price Target: $85$90
Current: $13.37
Upside: +573.15%
Upgrades: Overweight
Price Target: n/a
Current: $62.75
Upside: -